Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in Heart Failure with Obstructive Airways Disease
NCT00562692Phase 3Terminated
- Sponsor
- Alfred Health
- Start
- Sep 2007
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) and chronic obstructive pulmonary disease (COPD) comparing Nesiritide with Placebo (2 arms). Primary endpoint: Need for and length of time patients require non invasive ventilation at 24 hours. Started Sep 2007; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00562692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562692.